1246213-24-0 Usage
Uses
1. Used in Pharmaceutical Industry:
Benzeneacetic acid, 4-[[(1,4-dihydro-4-oxo-3-quinolinyl)carbonyl]amino]-5-(1,1-dimethylethyl)-2-hydroxy-α,α-dimethylis used as an intermediate compound for the synthesis of various pharmaceuticals. Its unique structure may provide specific biological activities or serve as a building block for the development of new drugs.
2. Used in Chemical Research:
Benzeneacetic acid, 4-[[(1,4-dihydro-4-oxo-3-quinolinyl)carbonyl]aMino]-5-(1,1-diMethylethyl)-2-hydroxy-α,α-diMethylcan be utilized in chemical research for understanding the properties and reactivity of complex organic molecules. It may also be used as a reference material for the development of new synthetic methods or analytical techniques.
3. Used in Impurity Analysis:
As an impurity of Ivacaftor (I940600), a drug used in the treatment of cystic fibrosis, Benzeneacetic acid, 4-[[(1,4-dihydro-4-oxo-3-quinolinyl)carbonyl]amino]-5-(1,1-dimethylethyl)-2-hydroxy-α,α-dimethylmay be used for quality control and impurity profiling in the pharmaceutical industry. This helps ensure the safety and efficacy of the drug by monitoring and controlling the presence of impurities.
Check Digit Verification of cas no
The CAS Registry Mumber 1246213-24-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,6,2,1 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1246213-24:
(9*1)+(8*2)+(7*4)+(6*6)+(5*2)+(4*1)+(3*3)+(2*2)+(1*4)=120
120 % 10 = 0
So 1246213-24-0 is a valid CAS Registry Number.
1246213-24-0Relevant articles and documents
PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
-
Page/Page column 75; 79, (2010/10/03)
The invention provides a process for the preparation of a compound of Formula 1; comprising coupling a carboxylic acid of Formula 2; with an aniline of Formula 3; in the presence of a coupling agent.
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
-
Page/Page column 15; 45; 49, (2010/10/03)
This invention relates to a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein R is COOH or CH2OH.